VRS
ENTA icon

Virginia Retirement Systems’s Enanta Pharmaceuticals ENTA Stock Holding History

Virginia Retirement Systems’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,800
Closed -$359 – 1142
2021
Q4 		$359 Sell
4,800
-7,900
-62% -$620K ﹤0.01% 940
2021
Q3 		$721K Sell
12,700
-11,500
-48% -$568K 0.01% 711
2021
Q2 		$1.06M Buy
24,200
+100
+0.4% +$4.9K 0.01% 626
2021
Q1 		$1.19M Buy
24,100
+6,000
+33% +$299K 0.01% 595
2020
Q4 		$762K Buy
18,100
+3,300
+22% +$145K 0.01% 693
2020
Q3 		$678K Buy
14,800
+1,500
+11% +$72.7K 0.01% 658
2020
Q2 		$668K Buy
13,300
+1,300
+11% +$67.3K 0.01% 706
2020
Q1 		$617K Sell
12,000
-800
-6% -$42.6K 0.01% 723
2019
Q4 		$791K Buy
12,800
+2,200
+21% +$136K 0.01% 782
2019
Q3 		$637K Buy
10,600
+700
+7% +$52K 0.01% 838
2019
Q2 		$835K Buy
9,900
+500
+5% +$45K 0.01% 733
2019
Q1 		$898K Sell
9,400
-1,600
-15% -$144K 0.01% 712
2018
Q4 		$779K Buy
11,000
+1,200
+12% +$92K 0.01% 713
2018
Q3 		$838K Buy
+9,800
New +$982K 0.01% 763
2018
Q2 		– Sell
-9,600
Closed -$777K – 1053
2018
Q1 		$777K Sell
9,600
-11,500
-55% -$885K 0.01% 726
2017
Q4 		$1.24M Sell
21,100
-23,100
-52% -$1.16M 0.01% 597
2017
Q3 		$2.07M Sell
44,200
-21,700
-33% -$872K 0.03% 492
2017
Q2 		$2.37M Buy
65,900
+1,400
+2% +$44.8K 0.03% 440
2017
Q1 		$1.99M Buy
64,500
+36,100
+127% +$1.12M 0.03% 475
2016
Q4 		$951K Sell
28,400
-6,900
-20% -$198K 0.01% 599
2016
Q3 		$939K Buy
35,300
+10,800
+44% +$251K 0.01% 571
2016
Q2 		$540K Buy
+24,500
New +$641K 0.01% 692
2015
Q4 		$525K Sell
15,900
-12,300
-44% -$401K 0.01% 712
2015
Q3 		$1.02M Sell
28,200
-300
-1% -$12.9K 0.02% 537
2015
Q2 		$1.28M Buy
28,500
+15,600
+121% +$607K 0.02% 479
2015
Q1 		$395K Buy
+12,900
New +$502K 0.01% 768

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virginia Retirement Systems's ENTA Position: Q1 2022 in Review

Virginia Retirement Systems sold out of Enanta Pharmaceuticals (ENTA) in Q1 2022, closing a stake of 4,800 shares — an estimated $359 sold.

Virginia Retirement Systems first reported a position in ENTA in Q1 2015 and held it in 26 quarters. The position peaked at $2.37M in Q2 2017. 169 funds tracked by Wall St. Rank hold ENTA as of Q1 2022.

  • Virginia Retirement Systems reported no remaining Enanta Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 4,800 Enanta Pharmaceuticals shares in Q1 2022, an estimated $359.
  • Virginia Retirement Systems first reported a position in Enanta Pharmaceuticals in Q1 2015 and held it in 26 quarters.
  • Virginia Retirement Systems's Enanta Pharmaceuticals position peaked at $2.37M in Q2 2017.
  • 169 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.